Recent News

• 06.06.2025 - Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
• 06.06.2025 - Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
• 05.14.2025 - Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights
• 05.14.2025 - Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights
• 04.08.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.08.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.01.2025 - Nkarta to Participate in an April Investor Conference
• 04.01.2025 - Nkarta to Participate in an April Investor Conference
• 03.26.2025 - Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
• 03.26.2025 - Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights

Recent Filings

• 05.14.2025 - 8-K Current report
• 05.14.2025 - EX-99.1 EX-99.1
• 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.21.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.21.2025 - DEF 14A Other definitive proxy statements
• 04.21.2025 - ARS Annual Report to Security Holders
• 03.26.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.26.2025 - 8-K Current report
• 03.26.2025 - EX-99.1 EX-99.1